MVP Stock Overview
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Medical Developments International Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.56 |
| 52 Week High | AU$1.80 |
| 52 Week Low | AU$0.54 |
| Beta | 1.61 |
| 1 Month Change | -5.88% |
| 3 Month Change | -39.78% |
| 1 Year Change | -44.83% |
| 3 Year Change | -89.72% |
| 5 Year Change | -90.09% |
| Change since IPO | 16.67% |
Recent News & Updates
Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge
Mar 11
Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward
Jan 16Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?
Jan 03Recent updates
Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge
Mar 11Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward
Jan 16Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?
Jan 03Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?
Aug 09We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate
Apr 24Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?
Jul 04Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates
Mar 04Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates
Mar 05If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns
Feb 07Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)
Dec 16Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Dec 10
Shareholder Returns
| MVP | AU Pharmaceuticals | AU Market | |
|---|---|---|---|
| 7D | 1.8% | -1.7% | 0.9% |
| 1Y | -44.8% | 31.3% | 5.6% |
Return vs Industry: MVP underperformed the Australian Pharmaceuticals industry which returned 31.3% over the past year.
Return vs Market: MVP underperformed the Australian Market which returned 5.6% over the past year.
Price Volatility
| MVP volatility | |
|---|---|
| MVP Average Weekly Movement | 8.0% |
| Pharmaceuticals Industry Average Movement | 10.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: MVP's share price has been volatile over the past 3 months.
Volatility Over Time: MVP's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1971 | n/a | Brent MacGregor | medicaldev.com |
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers respiratory devices for sufferers of asthma and chronic obstructive pulmonary disease (COPD); and Penthrox, a trauma and emergency pain relief product; and medical devices.
Medical Developments International Limited Fundamentals Summary
| MVP fundamental statistics | |
|---|---|
| Market cap | AU$48.33m |
| Earnings (TTM) | -AU$19.21m |
| Revenue (TTM) | AU$33.55m |
1.4x
P/S Ratio-2.5x
P/E RatioIs MVP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MVP income statement (TTM) | |
|---|---|
| Revenue | AU$33.55m |
| Cost of Revenue | AU$10.17m |
| Gross Profit | AU$23.38m |
| Other Expenses | AU$42.59m |
| Earnings | -AU$19.21m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.22 |
| Gross Margin | 69.69% |
| Net Profit Margin | -57.27% |
| Debt/Equity Ratio | 0% |
How did MVP perform over the long term?
See historical performance and comparison